About: Evaluation of Crimean-Congo hemorrhagic fever virus in vitro inhibition by chloroquine and chlorpromazine, two FDA approved molecules   Goto Sponge  NotDistinct  Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

AttributesValues
type
isDefinedBy
title
  • Evaluation of Crimean-Congo hemorrhagic fever virus in vitro inhibition by chloroquine and chlorpromazine, two FDA approved molecules
Creator
  • Emonet, S
  • Ferraris, O
  • Moroso, M
  • Paranhos-Baccalà, G
  • Pernet, O
  • Peyrefitte, C
  • Rembert, A
source
  • Elsevier; Medline; PMC
abstract
has issue date
bibo:doi
  • 10.1016/j.antiviral.2015.03.005
bibo:pmid
  • 25796972
has license
  • els-covid
sha1sum (hex)
  • f01c3291d0606eb286f17281da9f906eabb24d94
schema:url
resource representing a document's title
has PubMed Central identifier
  • PMC7113845
has PubMed identifier
  • 25796972
schema:publication
  • Antiviral Research
resource representing a document's body
is schema:about of
Faceted Search & Find service v1.13.91 as of Mar 24 2020


Alternative Linked Data Documents: Sponger | ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software